Tekla Healthcare Investors

HQH · NYSE · Financial Services / Asset Management

21.43USD+0.10 (+0.47%)

Price History

Full chart

Market Stats

Previous Close21.33

Open21.18

Day Range21.09 – 21.45

52-Week Range15.53 – 24.18

Volume83.09K

Market Cap1.22B

P/E (TTM)4.84

Forward P/E0.00

EPS4.40

Dividend Yield11.60%

Beta0.74

50-Day Avg22.39

200-Day Avg20.17

About

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Company Details

SectorFinancial Services
IndustryAsset Management
CEODr. Daniel R. Omstead M.S, Ph.D.
Employees0
Headquarters1900 Market Street, Philadelphia, PA, United States, 19103, USA
Websitehttps://www.teklacap.com/hqh.html

Leadership

Dr. Daniel R. Omstead M.S, Ph.D.Portfolio Manager · b. 1953
Dr. Jason C. Akus M.B.A., M.D.Vice President of Research and Portfolio Manager
Mr. Christopher F. Brinzey MBASenior Vice President of Research and Portfolio Manager
Dr. Frank T. Gentile Ph.D.Senior Vice President of Research and Portfolio Manager · b. 1962

Financials

Income Statement

Currency: USD	1996-09-30	1997-09-30	1998-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1996-09-30	1997-09-30	1998-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	250.00K	680.00K	640.00K	2.08M	2.85M	1.50M	990.00K	690.00K	1.49M	3.19M	2.17M	2.19M	720.00K	3.57M	1.87M	5.04M	1.96M	2.14M	4.33M	4.80M	123.06M	70.97M	-143.63M	242.92M	157.10M	-192.26M	58.12M	10.77M	99.81M
Growth (%)	-	+172.00%	-5.88%	+225.00%	+37.02%	-47.37%	-34.00%	-30.30%	+115.94%	+114.09%	-31.97%	+0.92%	-67.12%	+395.83%	-47.62%	+169.61%	-61.19%	+9.59%	+102.03%	+10.85%	+2463.01%	-42.33%	-302.38%	+269.13%	-35.33%	-222.38%	+130.23%	-81.47%	+826.84%
Cost of Revenue	2.09M	2.19M	2.46M	4.81M	4.68M	4.51M	3.77M	4.52M	5.16M	5.26M	5.27M	5.54M	4.22M	4.40M	4.78M	5.17M	6.16M	8.45M	11.45M	10.17M	9.84M	10.02M	9.63M	10.05M	11.76M	11.30M	10.90M	10.49M	-
Gross Profit	-1.84M	-1.51M	-1.82M	-2.73M	-1.83M	-3.01M	-2.78M	-3.83M	-3.67M	-2.07M	-3.10M	-3.35M	-3.50M	-830.00K	-2.91M	5.04M	1.96M	2.14M	4.33M	4.80M	123.06M	70.97M	-143.63M	242.92M	157.10M	-192.26M	58.12M	10.77M	99.81M
Gross Margin	-736.00%	-222.06%	-284.38%	-131.25%	-64.21%	-200.67%	-280.81%	-555.07%	-246.31%	-64.89%	-142.86%	-152.97%	-486.11%	-23.25%	-155.61%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Expense	180.00K	220.00K	230.00K	330.00K	390.00K	580.00K	460.00K	670.00K	750.00K	800.00K	1.00M	830.00K	760.00K	800.00K	1.13M	6.30M	7.24M	9.30M	12.18M	11.08M	1.78M	1.77M	1.66M	1.72M	1.93M	1.96M	1.78M	10.99M	1.20M
Operating Income	-2.02M	-1.73M	-2.05M	-3.06M	-2.22M	-3.59M	-3.24M	-4.50M	-4.42M	-2.87M	-4.10M	-4.18M	-4.26M	-1.63M	-4.04M	-1.26M	-5.28M	-7.16M	-7.85M	-6.28M	121.28M	69.20M	-145.29M	241.20M	155.18M	-194.23M	56.33M	-220.27K	98.61M
Operating Margin	-808.00%	-254.41%	-320.31%	-147.12%	-77.89%	-239.33%	-327.27%	-652.17%	-296.64%	-89.97%	-188.94%	-190.87%	-591.67%	-45.66%	-216.04%	-24.99%	-269.87%	-333.81%	-181.25%	-130.86%	98.56%	97.51%	101.16%	99.29%	98.77%	101.02%	96.93%	-2.05%	98.80%
EBITDA	56.75M	42.40M	-41.68M	322.31M	-76.79M	-42.06M	80.93M	46.67M	97.06M	6.17M	112.36M	-23.64M	-40.11M	15.44M	43.11M	159.11M	205.36M	229.17M	104.02M	-49.74M	126.45M	73.32M	-142.42M	243.18M	161.41M	-190.56M	56.33M	-	98.61M
EBITDA Margin	22700.00%	6235.29%	-6512.50%	15495.67%	-2694.39%	-2804.00%	8174.75%	6763.77%	6514.09%	193.42%	5177.88%	-1079.45%	-5570.83%	432.49%	2305.35%	3155.82%	10496.33%	10688.77%	2401.36%	-1035.87%	102.75%	103.32%	99.16%	100.10%	102.74%	99.11%	96.93%	-	98.80%
Net Income	29.97M	33.17M	-47.20M	286.61M	-140.29M	-75.94M	54.55M	13.36M	62.62M	-15.02M	75.23M	-23.85M	-36.44M	19.64M	32.36M	157.84M	200.08M	222.02M	96.17M	-56.02M	121.28M	69.20M	-145.29M	241.20M	155.18M	-194.23M	56.33M	184.95M	98.61M
Net Income Margin	11988.00%	4877.94%	-7375.00%	13779.33%	-4922.46%	-5062.67%	5510.10%	1936.23%	4202.68%	-470.85%	3466.82%	-1089.04%	-5061.11%	550.14%	1730.48%	3130.73%	10226.64%	10354.95%	2220.11%	-1166.73%	98.56%	97.51%	101.16%	99.29%	98.77%	101.02%	96.93%	1717.36%	98.80%
R&D	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.69	2.62	1.74	2.6	0.56	-	-
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.00%	0.00%	0.00%	-0.00%	0.00%	-	-
Interest Expense	26.78M	9.23M	5.52M	35.70M	63.50M	33.88M	26.38M	33.31M	34.44M	21.19M	37.13M	210.00K	3.67M	4.20M	10.75M	510.00K	205.36M	229.17M	104.02M	49.74M	0	0	0	0	0	-	-	-	-
Interest Expense % of Total Revenue	10712.00%	1357.35%	862.50%	1716.35%	2228.07%	2258.67%	2664.65%	4827.54%	2311.41%	664.26%	1711.06%	9.59%	509.72%	117.65%	574.87%	10.12%	10496.48%	10688.58%	2401.36%	1035.87%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-	-	-

Balance Sheet

Currency: USD	1996-09-30	1997-09-30	1998-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1996-09-30	1997-09-30	1998-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	148.30M	208.00M	158.20M	486.40M	330.40M	242.50M	291.50M	371.60M	418.50M	386.90M	444.70M	407.50M	365.40M	375.50M	381.60M	511.00M	691.00M	1.05B	1.12B	1.01B	1.07B	1.09B	877.78M	1.06B	1.17B	926.28M	932.49M	1.06B	1.10B
Total Liabilities	700.00K	300.00K	200.00K	800.00K	1.00M	500.00K	4.70M	2.30M	1.40M	1.80M	700.00K	4.50M	9.10M	10.30M	2.70M	600.00K	900.00K	1.13M	13.70M	34.79M	9.76M	3.76M	6.93M	1.12M	15.63M	9.71M	1.15M	1.40M	3.43M
Total Equity	147.60M	207.70M	158.00M	485.60M	329.40M	242.00M	286.80M	369.30M	417.10M	385.10M	444.00M	403.00M	356.30M	365.20M	378.90M	510.40M	690.10M	1.05B	1.10B	974.78M	1.06B	1.08B	870.85M	1.05B	1.16B	916.56M	931.34M	1.06B	1.09B
Cash	300.00K	-	200.00K	300.00K	600.00K	-	2.00M	200.00K	300.00K	781	1.39K	958	-	-	-	-	-	1.12K	209.55K	883	6.46M	927	1.65M	-2.46M	935	792	214	56	59
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31.40K	11.33M	8.50M	-	-	-
Net Debt	-300.00K	-	-200.00K	-300.00K	-600.00K	-	-2.00M	-200.00K	-300.00K	-	-	-	-	-	-	-	-	-1.12K	-209.55K	-883	-6.46M	-927	-1.65M	2.49M	11.33M	8.49M	-214	-56	-59

Cash Flow

Currency: USD	1996-09-30	1997-09-30	1998-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1996-09-30	1997-09-30	1998-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	-2.02M	-1.67M	-2.10M	-2.59M	-2.45M	-3.77M	-3.32M	-4.87M	-5.32M	-4.11M	-5.14M	-6.52M	-2.66M	10.74M	18.61M	26.38M	20.37M	-141.08M	-	-	-	-	-	-	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-	-	-	-	-	20.86M	23.71M	23.71M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-3.49M	27.01M	-2.56M	-10.55M	-15.93M	-11.43M	-9.80M	69.19M	-14.81M	-17.00M	-16.31M	-17.19M	-10.26M	-10.74M	-18.61M	-26.38M	-20.37M	141.08M	-	-	-	-	-	-	-	-	-	-	-
Capital Expenditure	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-2.02M	-1.67M	-2.10M	-2.59M	-2.45M	-3.77M	-3.32M	-4.87M	-5.32M	-4.11M	-5.14M	-6.52M	-2.66M	10.74M	18.61M	26.38M	20.37M	-141.08M	-	-	-	-	-	-	-	-	-	-	-
Dividends Paid	6.77M	14.78M	2.56M	10.55M	15.93M	11.43M	9.80M	10.97M	14.81M	17.00M	16.31M	17.19M	10.26M	5.12M	16.74M	16.43M	20.37M	31.22M	-	-	-	-	-	-	-	-	-	-	-
FCF to OCF	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	-	-	-	-	-	-	-	-	-	-
Dividend Paid to FCF	-335.15%	-885.03%	-121.90%	-407.34%	-650.20%	-303.18%	-295.18%	-225.26%	-278.38%	-413.63%	-317.32%	-263.65%	-385.71%	47.67%	89.95%	62.29%	100.00%	-22.13%	-	-	-	-	-	-	-	-	-	-	-

Earnings

Report Date	Dec 31, 2010	Mar 31, 2011	Jun 30, 2011	Sep 30, 2011	Dec 31, 2011	Mar 31, 2012	Jun 30, 2012	Sep 30, 2012	Dec 31, 2012	Mar 31, 2013	Jun 30, 2013	Sep 30, 2013	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Sep 30, 2014	Dec 31, 2014	Mar 31, 2015	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Jun 3, 2016	Sep 30, 2016	Dec 1, 2016	Mar 31, 2017	Jun 2, 2017	Sep 30, 2017	Dec 5, 2017	Mar 31, 2018	Jun 1, 2018	Sep 30, 2018	Dec 4, 2018	Mar 31, 2019	Jun 5, 2019	Sep 30, 2019	Dec 5, 2019	Mar 31, 2020	Jun 5, 2020	Sep 30, 2020	Dec 4, 2020	Mar 31, 2021	Jun 4, 2021	Sep 30, 2021	Dec 3, 2021	Jun 3, 2022	Dec 7, 2022	Dec 9, 2024	Jun 9, 2025	Dec 8, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	1.04	1.04	-0.40	-0.40	1.99	1.99	1.03	1.03	1.22	1.22	2.41	2.41	1.65	1.65	1.80	1.80	2.81	2.81	-1.46	-1.46	-1.55	-1.55	-3.10	0.80	1.57	0.45	0.90	1.05	2.07	-0.79	-1.58	1.60	3.14	-1.00	-1.99	-0.71	-1.41	0.56	1.11	2.20	4.33	0.99	1.98	0.73	1.44	-2.48	-1.64	1.59	-1.39	3.03
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.22B

Enterprise Value1.06B

Trailing P/E4.84

Forward P/E0.00

PEG Ratio0.00

Price / Sales219.72

Price / Book1.09

EPS4.40

Book Value19.88

Revenue (TTM)5.54M

Gross Profit (TTM)5.54M

Profit Margin4561.32%

Operating Margin-125.50%

Return on Equity24.21%

Return on Assets-0.35%

Shares Outstanding57.19M

Shares Float0

Beta0.74

Dividend Yield11.60%

Dividend Rate2.47

Payout Ratio81.52%

Dividends

20263×

0.66Aug 24, 20260.61May 21, 20260.63Feb 20, 2026

20254×

0.57Nov 21, 20250.51Aug 22, 20250.54May 22, 20250.57Feb 21, 2025

20244×

0.62Nov 21, 20240.59Aug 23, 20240.59May 22, 20240.48Feb 21, 2024

20234×

0.38Nov 21, 20230.40Aug 24, 20230.40May 24, 20230.42Feb 24, 2023

20224×

0.39Nov 23, 20220.40Aug 25, 20220.44May 26, 20220.48Feb 24, 2022

20214×

0.51Nov 23, 20210.52Aug 26, 20210.50May 27, 20210.51Feb 25, 2021

20201×

0.05Dec 30, 2020